128 related articles for article (PubMed ID: 16154929)
1. Amyloid precursor protein: from synaptic plasticity to Alzheimer's disease.
Mileusnic R; Lancashire CL; Rose SP
Ann N Y Acad Sci; 2005 Jun; 1048():149-65. PubMed ID: 16154929
[TBL] [Abstract][Full Text] [Related]
2. APP is required during an early phase of memory formation.
Mileusnic R; Lancashire CL; Johnston AN; Rose SP
Eur J Neurosci; 2000 Dec; 12(12):4487-95. PubMed ID: 11122359
[TBL] [Abstract][Full Text] [Related]
3. The peptide sequence Arg-Glu-Arg, present in the amyloid precursor protein, protects against memory loss caused by A beta and acts as a cognitive enhancer.
Mileusnic R; Lancashire CL; Rose SP
Eur J Neurosci; 2004 Apr; 19(7):1933-8. PubMed ID: 15078567
[TBL] [Abstract][Full Text] [Related]
4. The memory enhancing effect of the APP-derived tripeptide Ac-rER is mediated through CRMP2.
Mileusnic R; Rose SP
J Neurochem; 2011 Aug; 118(4):616-25. PubMed ID: 21255016
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
6. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
7. Protection against Abeta-induced memory loss by tripeptide D-Arg-L-Glu-L-Arg.
Mileusnic R; Lancashire C; Clark J; Rose SP
Behav Pharmacol; 2007 May; 18(3):231-8. PubMed ID: 17426487
[TBL] [Abstract][Full Text] [Related]
8. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V
Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243
[TBL] [Abstract][Full Text] [Related]
9. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
Marcello E; Epis R; Di Luca M
Eur J Pharmacol; 2008 May; 585(1):109-18. PubMed ID: 18377893
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning.
Senechal Y; Kelly PH; Dev KK
Behav Brain Res; 2008 Jan; 186(1):126-32. PubMed ID: 17884188
[TBL] [Abstract][Full Text] [Related]
11. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein expression in the rat hippocampal dentate gyrus modulates during memory consolidation.
Conboy L; Murphy KJ; Regan CM
J Neurochem; 2005 Dec; 95(6):1677-88. PubMed ID: 16236032
[TBL] [Abstract][Full Text] [Related]
13. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
14. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
15. From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein.
Octave JN; Pierrot N; Ferao Santos S; Nalivaeva NN; Turner AJ
J Neurochem; 2013 Jul; 126(2):183-90. PubMed ID: 23495999
[TBL] [Abstract][Full Text] [Related]
16. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway.
Randall AD; Witton J; Booth C; Hynes-Allen A; Brown JT
Neuropharmacology; 2010; 59(4-5):243-67. PubMed ID: 20167227
[TBL] [Abstract][Full Text] [Related]
17. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
Hasegawa T
Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
[TBL] [Abstract][Full Text] [Related]
19. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
